Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 443
6
Diseases
17
Unique genes
0.205
Avg. similarity score
Congenital microvillous atrophy
Most-connected disease (3 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital microvillous atrophy
Diarrhea 2, with microvillus atrophy
Intestinal disease
Microvillus inclusion disease
Diarrhea 12, with microvillus atrophy
Intestinal dysmotility syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital microvillous atrophy | 3 | 3 | 1 |
| Diarrhea 2, with microvillus atrophy | 3 | 3 | 1 |
| Intestinal disease | 3 | 3 | 15 |
| Microvillus inclusion disease | 3 | 3 | 3 |
| Diarrhea 12, with microvillus atrophy | 1 | 1 | 1 |
| Intestinal dysmotility syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MYO5B | 4 / 6 | Congenital microvillous atrophy, Diarrhea 2, with microvillus atrophy, Intestinal disease, Microvillus inclusion disease |
| ANO1 | 2 / 6 | Intestinal disease, Intestinal dysmotility syndrome |
| STX3 | 2 / 6 | Diarrhea 12, with microvillus atrophy, Microvillus inclusion disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Toxoplasmosis | KEGG | 3 / 112 | 18.9× | 4.88e-4 | 6.56e-3 ✓ sig. |
| activated TAK1 mediates p38 MAPK activation | Reactome | 2 / 24 | 58.9× | 5.11e-4 | 6.78e-3 ✓ sig. |
| Other interleukin signaling | Reactome | 2 / 24 | 58.9× | 5.11e-4 | 6.78e-3 ✓ sig. |
| NOD1/2 Signaling Pathway | Reactome | 2 / 36 | 39.2× | 1.15e-3 | 1.27e-2 ✓ sig. |
| Tuberculosis | KEGG | 3 / 181 | 11.7× | 1.96e-3 | 1.88e-2 ✓ sig. |
| SDK interactions | Reactome | 1 / 2 | 353× | 2.83e-3 | 2.44e-2 ✓ sig. |
| Peroxisomal protein import | Reactome | 2 / 63 | 22.4× | 3.50e-3 | 2.83e-2 ✓ sig. |
| Pathways of neurodegeneration - multiple diseases | KEGG | 4 / 480 | 5.9× | 3.96e-3 | 3.11e-2 ✓ sig. |
| Inhibition of nitric oxide production | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.26e-2 ✓ sig. |
| Nitric oxide stimulates guanylate cyclase | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.26e-2 ✓ sig. |
| Pertussis | KEGG | 2 / 78 | 18.1× | 5.32e-3 | 3.80e-2 ✓ sig. |
| Leishmaniasis | KEGG | 2 / 78 | 18.1× | 5.32e-3 | 3.80e-2 ✓ sig. |
| Peroxisome | KEGG | 2 / 83 | 17.0× | 6.00e-3 | 4.10e-2 ✓ sig. |
| Prion disease | KEGG | 3 / 275 | 7.7× | 6.37e-3 | 4.28e-2 ✓ sig. |
| Chagas disease | KEGG | 2 / 103 | 13.7× | 9.11e-3 | 5.37e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of interleukin-8 production | GO:0032757 | 3 / 65 | 50.7× | 2.64e-5 | 1.13e-3 ✓ sig. |
| regulation of cytokine production involved in inflammatory response | GO:1900015 | 2 / 11 | 200× | 4.26e-5 | 1.63e-3 ✓ sig. |
| response to muramyl dipeptide | GO:0032495 | 2 / 13 | 169× | 6.04e-5 | 2.13e-3 ✓ sig. |
| p38MAPK cascade | GO:0038066 | 2 / 26 | 84.6× | 2.50e-4 | 5.95e-3 ✓ sig. |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 2 / 32 | 68.7× | 3.80e-4 | 7.89e-3 ✓ sig. |
| cell surface receptor protein serine/threonine kinase signaling pathway | GO:0007178 | 2 / 33 | 66.6× | 4.05e-4 | 8.24e-3 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 3 / 187 | 17.6× | 6.05e-4 | 1.08e-2 ✓ sig. |
| cell redox homeostasis | GO:0045454 | 2 / 44 | 50.0× | 7.21e-4 | 1.21e-2 ✓ sig. |
| intrinsic apoptotic signaling pathway in response to nitrosative stress | GO:1990442 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| detection of muramyl dipeptide | GO:0032498 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| positive regulation of gamma-delta T cell activation | GO:0046645 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| neural plate mediolateral regionalization | GO:0021998 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| paraxial mesoderm structural organization | GO:0048352 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| neural plate pattern specification | GO:0060896 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| positive regulation of cardiac ventricle development | GO:1904414 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Congenital microvillous atrophy | Diarrhea 2, with microvillus atrophy | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Congenital microvillous atrophy | Microvillus inclusion disease | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Diarrhea 12, with microvillus atrophy | Microvillus inclusion disease | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Diarrhea 2, with microvillus atrophy | Microvillus inclusion disease | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Congenital microvillous atrophy | Intestinal disease | 0.063 | 1 | 9.68e-4 | 1.50e-3 ✓ sig. |
| Diarrhea 2, with microvillus atrophy | Intestinal disease | 0.063 | 1 | 9.68e-4 | 1.50e-3 ✓ sig. |
| Intestinal disease | Intestinal dysmotility syndrome | 0.063 | 1 | 9.68e-4 | 1.50e-3 ✓ sig. |